ADDvise receives order worth approximately 8.7 MSEK - Regulatory information

13-05-2019   Regulatory press release

ADDvise Group AB's (publ) subsidiary Sonar Oy has received an order from Tampere University Hospital in Finland worth approximately 8.7 MSEK regarding X-ray equipment. The equipment will be used for medical diagnostics. Delivery of the equipment is planned to take place between Q3 2019 – Q1 2020.

 

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on May 13th 2019, 11:15 CET.
 

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North and Mangold Fondkommission AB, +46 8 503 015 50,
CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com